This HTML5 document contains 253 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://dx.doi.org/10.4155/
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q38757723
rdf:type
wikibase:Item
schema:description
scientific article published on 2 March 2016 мақолаи илмӣ 2016 nî lūn-bûn artículu científicu espublizáu en 2016 vetenskaplig artikel 2016年论文 tieteellinen artikkeli מאמר מדעי articol științific artigo científico 2016 թվականի մարտի 2-ին հրատարակված գիտական հոդված article scientifique artikulong pang-agham article scientific vedecký článok სამეცნიერო სტატია 2016년 논문 scientific article published on 2 March 2016 articolo scientifico teaduslik artikkel 2016年論文 наукова стаття, опублікована в березні 2016 2016年論文 artículo científico publicado en 2016 2016年论文 naučni članak 2016年论文 wetenschappelijk artikel научна статия научни чланак 2016年论文 tudományos cikk научни чланак artikel ilmiah vědecký článek artikull shkencor scientific article published on 2 March 2016 2016年论文 article científic bilimsel makale 2016年論文 επιστημονικό άρθρο 2016年の論文 artigo científico scienca artikolo vitskapeleg artikkel bài báo khoa học videnskabelig artikel บทความทางวิทยาศาสตร์ 2016年论文 2016年論文 artigo científico vitenskapelig artikkel مقالة علمية نشرت في 2 مارس 2016 artykuł naukowy wissenschaftlicher Artikel ২ মার্চ ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2016年論文 научная статья
p:P577
wds:Q38757723-E6B54C7D-D906-439B-A6FB-FDEF65C67EC1
wdt:P577
2016-03-02T00:00:00Z
p:P2860
wds:Q38757723-639E38FA-D0A0-49DD-B547-283C926A9DB1 wds:Q38757723-65AE44B7-9989-47C7-85DE-67A2137738CE wds:Q38757723-86D4655C-9BF2-4BD1-A090-F1086825B787 wds:Q38757723-8962028A-124D-4291-B209-BD8F25B8BD08 wds:Q38757723-89A4FA66-4DBA-445D-9821-FBCAF70AFB76 wds:Q38757723-8A485DDF-954A-41CC-BDA8-62DA88F13D93 wds:Q38757723-7E1F92A6-BA40-44EA-A7D0-8420EE141219 wds:Q38757723-7E8A7354-6F9F-4C97-AE59-59F505585C53 wds:Q38757723-841EF4C7-60AC-43C1-9CE1-4A8417E5E3A9 wds:Q38757723-A2604009-2BF5-4277-88C3-F45D054C1CE7 wds:Q38757723-AA049EF1-AD11-460B-8B29-0B61161D991A wds:Q38757723-ABF48C7E-7DAA-4CBE-A7DC-34992168D362 wds:Q38757723-AD6A360A-CFB9-4AD3-A3BF-C71FE2F68FD7 wds:Q38757723-9A41E3B8-DDD1-4386-94CA-77ECDD775CFE wds:Q38757723-9C1C0AF3-F3D6-402C-B319-442C52D5FA9D wds:Q38757723-B5D23F76-19C6-4060-9BA3-351BBD0F2C74 wds:Q38757723-B8C4B524-794F-49F0-B86F-7EBEBA8DF98E wds:Q38757723-BC79862B-3EEB-45A4-861D-F4E862A9D810 wds:Q38757723-B28F8907-174E-4AFE-AFC5-EB3C7D23CCFE wds:Q38757723-B398501C-408D-4EB2-8FA3-C83E5538DE22 wds:Q38757723-B3A2FE64-0203-4B38-8D64-D83A820284D7 wds:Q38757723-B45E9F21-E38D-46E8-A3A2-B3D96802F3A9 wds:Q38757723-C9073626-8F95-49CE-9D49-B241C4555B6A wds:Q38757723-C92A7465-C1DA-429E-BFEC-852DE04E11D9 wds:Q38757723-CA73409D-DA1E-4471-9045-EA664690F4CE wds:Q38757723-CB5D044C-C85B-437E-9213-F62DFFD185CE wds:Q38757723-C35A81D2-7537-443B-A8E9-CC4967BC48FC wds:Q38757723-C42D9336-D194-4967-9588-1DF631C66545 wds:Q38757723-C492B66B-330A-4819-8FAB-73087B0B1B49 wds:Q38757723-C5624580-0CCD-4BB4-BFE8-E9E80B65F5C4 wds:Q38757723-D02B5C8C-7B55-489C-8E39-3C11F8ECC865 wds:Q38757723-D25682CF-4907-42AB-8FCA-65D2616F4BEF wds:Q38757723-D4585187-F50E-4E4B-AF04-2F5DB67A214A wds:Q38757723-D58470BB-C825-408A-8A43-0CA468F30A4D wds:Q38757723-CB7FBCFB-A5C3-4E1C-A2D4-C00F518B166E wds:Q38757723-CD25E853-3755-4E80-8064-46E2D5A92DBF wds:Q38757723-CE35ECB2-93F5-4970-976E-81511635D8F1 wds:Q38757723-E18FE314-4882-4E25-BADC-AF2020243FA1 wds:Q38757723-E247CB71-EA46-4D61-AC5D-9085DE55FE19 wds:Q38757723-E44DA6D0-0A03-4E26-9081-9E01E5E27A93 wds:Q38757723-E47BC905-B7F6-4C49-94F6-8F854C530590 wds:Q38757723-D65E12EA-EB4C-43BD-A338-2EA189E5ABF3 wds:Q38757723-D8120CD6-BB7C-48CA-A742-F3956E0208B1 wds:Q38757723-D88500F4-582A-4492-9AF2-44E1FA2B1D3D wds:Q38757723-DF877F69-9A12-4291-8B87-43BE69ABF43F wds:Q38757723-F3F8E085-3717-4A1A-AB4E-37AFF897142E wds:Q38757723-F8B4195C-BC5A-47E2-A050-1BF0B1F5FB74 wds:Q38757723-FC9B8C3E-FAF5-491D-86CF-4EFE601186D7 wds:Q38757723-FFDBD73C-38AE-4DB3-8655-80C213DA9480 wds:Q38757723-ED7A2590-269E-46FA-9425-DC1FB0D9BCE5 wds:Q38757723-F0A8C05A-4DD3-4279-AADD-9C06C9080AD0 wds:Q38757723-0015A0D7-2977-4327-9946-09691773F9B4 wds:Q38757723-0415FC5C-28ED-40C5-89FA-54DBA958F013 wds:Q38757723-0862E705-BF45-4603-AFD2-D83B7324C213 wds:Q38757723-1FE3316A-142C-4974-8B38-467FBE2E5945 wds:Q38757723-26B37E20-83EB-4D3E-9134-3AFDBC749BD3 wds:Q38757723-28F69B7D-C57F-409D-BB60-D9701BFD065F wds:Q38757723-29300EE0-7ABC-4A56-B226-18A51696605C wds:Q38757723-08E0C744-A3BF-4589-9527-FA80052B9055 wds:Q38757723-15F13DA5-FE7E-4C8E-841C-CA7E3BF69DEC wds:Q38757723-16545138-2B2D-4DA2-85C9-4EC805CBAC2E wds:Q38757723-329FC4CE-1A77-4DDA-BA39-14880ADBDFCF wds:Q38757723-34566F5C-2F05-4601-9ED7-A1254B32B39C wds:Q38757723-36DBB736-99E2-4063-AEF1-C3AA67F170F7 wds:Q38757723-396086DD-0203-4B3F-9B7F-584BCF3BF4D0 wds:Q38757723-294BF6EC-40D2-4C47-AA81-B45DBB8A6F06 wds:Q38757723-2C3D7522-2003-4D4E-B067-DD0245448B70 wds:Q38757723-30B9EF95-166C-4DE0-8A08-B08A7F43B48F wds:Q38757723-30F27EDB-4932-40DB-9FD8-D98E63ACCD5B wds:Q38757723-511295BD-000B-49B2-9E6E-97B1379CE2D6 wds:Q38757723-513C759C-4BFE-4BC7-A62E-DB73454B890C wds:Q38757723-53CD3A0A-6D3D-4BE5-A03C-CBF501DC866F wds:Q38757723-57B2D98E-DAE3-4D40-82C3-0E43E0B41501 wds:Q38757723-3BB35CA9-303A-4E29-94B7-07489ED3C593 wds:Q38757723-4239D418-66BA-4B6C-BE7F-7F8A2093968C wds:Q38757723-6A02533E-97E7-4C63-B0BF-A70044B2E9CB wds:Q38757723-6C9F4F6A-56CA-4597-A8AC-F08DD08242AF wds:Q38757723-7680E3E9-19CB-4AF8-85CB-DA63D620121F wds:Q38757723-77F81F97-A65D-4AE5-9506-D5918DE68FE4 wds:Q38757723-5E18411E-B97E-4291-95BF-45798B069E1C wds:Q38757723-601B95B6-303F-408A-AD4C-AB3B2CE84D56
wdt:P2860
wd:Q35043016 wd:Q34552576 wd:Q34122191 wd:Q36851327 wd:Q34978329 wd:Q36347314 wd:Q33947807 wd:Q33415219 wd:Q37857949 wd:Q38173072 wd:Q33627739 wd:Q33380559 wd:Q30469815 wd:Q37601970 wd:Q36756648 wd:Q37346912 wd:Q37832871 wd:Q40191493 wd:Q35544060 wd:Q52625890 wd:Q38264533 wd:Q34078666 wd:Q37534993 wd:Q34152769 wd:Q50912525 wd:Q28255366 wd:Q37518288 wd:Q37111141 wd:Q38165603 wd:Q27016629 wd:Q27007084 wd:Q37887909 wd:Q38548009 wd:Q26800587 wd:Q36848153 wd:Q34030791 wd:Q33361906 wd:Q34151507 wd:Q34056376 wd:Q29614537 wd:Q37422804 wd:Q38346010 wd:Q40662071 wd:Q52619102 wd:Q38125964 wd:Q53190500 wd:Q29615445 wd:Q37883025 wd:Q24630255 wd:Q42575030 wd:Q34791610 wd:Q36253306 wd:Q38107793 wd:Q37121685 wd:Q35539229 wd:Q37781199 wd:Q24608005 wd:Q24608039 wd:Q38412802 wd:Q33406802 wd:Q38411931 wd:Q37671366 wd:Q27026051 wd:Q28282757 wd:Q26784068 wd:Q46325595 wd:Q44985655 wd:Q37994504 wd:Q38046514 wd:Q29614538 wd:Q33872751 wd:Q37313683 wd:Q29614938 wd:Q36977417 wd:Q34088265 wd:Q34983846 wd:Q35915719 wd:Q37983692 wd:Q37512303 wd:Q35135727 wd:Q35163538
p:P2093
wds:Q38757723-46A37501-5ED9-44DB-9FF6-C34BEA4AF787
wdt:P2093
Anne Close
rdfs:label
Antiangiogenesis and vascular disrupting agents in cancer: circumventing resistance and augmenting their therapeutic utility Antiangiogenesis and vascular disrupting agents in cancer: circumventing resistance and augmenting their therapeutic utility Antiangiogenesis and vascular disrupting agents in cancer: circumventing resistance and augmenting their therapeutic utility
skos:prefLabel
Antiangiogenesis and vascular disrupting agents in cancer: circumventing resistance and augmenting their therapeutic utility Antiangiogenesis and vascular disrupting agents in cancer: circumventing resistance and augmenting their therapeutic utility Antiangiogenesis and vascular disrupting agents in cancer: circumventing resistance and augmenting their therapeutic utility
schema:name
Antiangiogenesis and vascular disrupting agents in cancer: circumventing resistance and augmenting their therapeutic utility Antiangiogenesis and vascular disrupting agents in cancer: circumventing resistance and augmenting their therapeutic utility Antiangiogenesis and vascular disrupting agents in cancer: circumventing resistance and augmenting their therapeutic utility
p:P1476
wds:Q38757723-EFCFBAFC-C87E-4399-8D90-A38918F6A4A6
wdt:P1476
Antiangiogenesis and vascular disrupting agents in cancer: circumventing resistance and augmenting their therapeutic utility
p:P304
wds:Q38757723-CD6ACD83-3035-45F3-B9A5-ABBB76299F46
wdt:P304
443-462
p:P31
wds:Q38757723-10B112BB-B103-4576-A4E5-541CF8194B5F
wdt:P31
wd:Q13442814
p:P698
wds:Q38757723-99282675-CDFF-4B7B-83BD-4ADFD748FD54
wdtn:P698
n12:26933926
wdt:P698
26933926
p:P1433
wds:Q38757723-83A76C96-DC46-42FB-ABEA-AF21ED7F1D8E
wdt:P1433
wd:Q19280078
p:P433
wds:Q38757723-BA2B2608-3C63-4016-BDDC-5FA0E511FABC
p:P478
wds:Q38757723-9929DF67-0853-45A0-B814-0C0A1BFFFA00
wdt:P433
4
wdt:P478
8
p:P356
wds:Q38757723-4835E816-CFE9-49B6-9D18-8FD8845F1315
wdtn:P356
n10:FMC.16.6
wdt:P356
10.4155/FMC.16.6